Etaracizumab
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer.
Read more
€0.00
(tax incl.)
Reference:
HY-P99291
Brand: